Eptifibatide is a cyclic heptapeptide containing 6 amino acids and 1 mercaptopropionyl (des-amino cysteinyl) residue. An interchain disulfide bridge is formed between the cysteine amide and the mercaptopropionyl moieties. Chemically it is N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-Llysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic (1→6)-disulfide. Eptifibatide binds to the platelet receptor glycoprotein (GP) IIb/IIIa of human platelets and inhibits platelet aggregation.
keywords
- Eptifibatide acetate hmoov
- peptide
- CAS # 148031-34-9
ceev Paub meej
- ProName: Eptifibatide
- CasNo: 148031-34-9
- Molecular Formula: C35H49N11O9S2
- Tsos: Dawb hmoov
- Daim ntawv thov: Non-ceev percutaneous coronary inter ...
- DeliveryTime: pab zaub mov xa tuaj
- Pob: Raws li koj xav tau kev pab
- Chaw nres nkoj: Shenzhen
- ProductionCapacity: 5 kilogram / rau lub Hlis
- Purity: 98%
- Cia: 2 ~ 8 ℃, kev tiv thaiv los ntawm lub teeb
- Tsheb thauj mus los: los ntawm huab cua
- LimitNum: 1 gram
superiority
kev peptide chaw tsim tshuaj paus nyob rau hauv Tuam Tshoj.
zoo nrog GMP qib
loj scale nrog sis tw nqi
peb cov khoom muaj xws li: generic tej peptide APIs, kom hniav zoo nkauj peptide, kev cai peptides thiab kho tsiaj peptides.
molecular mis:
c35h49n11o9s 2
txheeb ze molecular loj:
831,97 g / mol
long-term cia:
-20 ± 5 ° c
ib theem zuj zus:
3-mercaptopropionyl-homoarg-gly-nab taug-trp-pro-cys-nh2 acetate ntsev (disulfide daim ntawv cog lus)
Paub meej
Tuam txhab Profile:
lub tuam txhab lub npe: Shenzhen JYMed Technology Co., Ltd.
Xyoo Tsim: 2009
Peev: 89,5 lab RMB
Main khoom: oxytocin acetate, Vasopressin acetate, Desmopressin acetate, Terlipressin acetate, Caspofungin acetate, Micafungin sodium, Eptifibatide acetate, Bivalirudin TFA, Deslorelin acetate, Glucagon acetate, Histrelin acetate, Liraglutide acetate, Linaclotide Aceteate, Degarelix acetate, Buserelin acetate, Cetrorelix acetate , Goserelin
Acetate, Argireline acetate, Metrixyl acetate, Snap-8, ... ..
Peb siv zog rau cov tseem nrhav nyob rau hauv tshiab peptide synthesis technology thiab cov txheej txheem optimization, thiab peb kev pab neeg muaj tshaj xyoo caum ntawm kev nyob rau hauv peptide synthesis.JYM tau ntse xa ntau
ntawm ANDA peptide APIs thiab formulated cov khoom uas muaj CFDA thiab muaj tshaj plaub caug patents pom zoo.
Peb peptide cog nyob rau hauv Nanjing, Jiangsu xeev thiab nws tau teem ib lub chaw ntawm 30,000 square meters nyob rau hauv kev ua raws cai nrog cGMP yeej. Cov kev siv thiab lub tsev raug audited thiab ntsuam xyuas los ntawm ob qho tib si domestic thiab thoob ntiaj teb neeg.
Nrog nws zoo heev zoo, feem ntau cov kev sib tw cov nqi thiab muaj zog kev them nyiaj yug, JYM tsis tsuas tau tau qhuas txog rau nws cov khoom los ntawm kev tshawb fawb cov koom haum thiab chaw ua tshuaj industries, tab sis kuj ua ib qho ntawm feem txhim khu kev qha lwm tus neeg uas peptides nyob rau hauv Tuam Tshoj ,. JYM yog nplooj siab mus yuav ib tug ntawm lub ntiaj teb no tus leading peptide mob nyob rau hauv lub nyob ze yav tom ntej.
